A study of microbial translocation markers in mastocytosis.
作者信息
Komarow Hirsh D, Brenchley Jason M, Eisch Andrea Robin, Young Michael L, Scott Linda M, Kulinski Joseph M, Heller Theo, Bai Yun, Metcalfe Dean D
机构信息
Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
出版信息
Clin Exp Allergy. 2021 Feb;51(2):369-372. doi: 10.1111/cea.13798. Epub 2020 Dec 10.
Abstract
摘要
相似文献
1
A study of microbial translocation markers in mastocytosis.一项关于肥大细胞增多症中微生物易位标志物的研究。
Clin Exp Allergy. 2021 Feb;51(2):369-372. doi: 10.1111/cea.13798. Epub 2020 Dec 10.
2
Biomarkers for assessment of intestinal permeability in clinical practice.用于临床评估肠通透性的生物标志物。
Am J Physiol Gastrointest Liver Physiol. 2021 Jul 1;321(1):G11-G17. doi: 10.1152/ajpgi.00113.2021. Epub 2021 May 19.
3
Mastocytosis.肥大细胞增多症
Chem Immunol Allergy. 2010;95:110-124. doi: 10.1159/000315946. Epub 2010 Jun 1.
4
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier.SARS-CoV-2 感染会扰乱胃肠道，并导致肠道屏障轻微的微生物易位。
J Virol. 2024 Oct 22;98(10):e0128824. doi: 10.1128/jvi.01288-24. Epub 2024 Sep 12.
5
Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut-Vascular Barrier Damage Across Stages of Cirrhosis.肝硬化各阶段肠道通透性、细菌移位和肠-血管屏障损伤的替代标志物
Liver Int. 2025 Jun;45(6):e70119. doi: 10.1111/liv.70119.
6
[Clinical variability in two cases of systemic mastocytosis].
Pol Arch Med Wewn. 2001 Apr;105(4):311-5.
7
Elevation in histamine and tryptase following exercise in patients with mastocytosis.肥大细胞增多症患者运动后组胺和类胰蛋白酶升高。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1310-1313.e2. doi: 10.1016/j.jaip.2018.07.008. Epub 2018 Jul 23.
8
Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene.从患有肥大细胞增多症且KIT基因携带杂合突变的患者中建立人诱导多能干细胞系（SDQLCHi005-A）。
Stem Cell Res. 2019 Oct;40:101565. doi: 10.1016/j.scr.2019.101565. Epub 2019 Sep 6.
9
Pathology of extramedullary mastocytosis.髓外肥大细胞增多症的病理学。
Immunol Allergy Clin North Am. 2014 May;34(2):323-39. doi: 10.1016/j.iac.2014.01.010.
10
Obesity and polycystic ovary syndrome influence on intestinal permeability at fasting, and modify the effect of diverse macronutrients on the gut barrier.肥胖症和多囊卵巢综合征会影响空腹时的肠道通透性，并改变不同宏量营养素对肠道屏障的影响。
Food Res Int. 2024 Jun;186:114338. doi: 10.1016/j.foodres.2024.114338. Epub 2024 Apr 18.
引用本文的文献
1
Evaluation of Intestinal Permeability Using Serum Biomarkers in Learning Early About Peanut Allergy Trial.在早期了解花生过敏试验中使用血清生物标志物评估肠道通透性
Allergy. 2025 Aug;80(8):2286-2296. doi: 10.1111/all.16464. Epub 2025 Jan 13.
2
Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosis.肥大细胞增多症患者嗜碱性粒细胞中甲酰肽受体-1表达增加。
J Allergy Clin Immunol Glob. 2024 Jul 3;3(4):100296. doi: 10.1016/j.jacig.2024.100296. eCollection 2024 Nov.
3
sCD14 and Intestinal Fatty Acid Binding Protein Are Elevated in the Serum of Patients With Idiopathic Anaphylaxis.特发性过敏症患者血清中 sCD14 和肠脂肪酸结合蛋白水平升高。
J Allergy Clin Immunol Pract. 2023 Jul;11(7):2080-2086.e5. doi: 10.1016/j.jaip.2023.03.037. Epub 2023 Mar 29.
本文引用的文献
1
Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.血清肠通透素在 IBS 中升高，并与 IBS-D 的粪便频率相关。
United European Gastroenterol J. 2019 Jun;7(5):709-715. doi: 10.1177/2050640619826419. Epub 2019 Jan 19.
2
Fluctuation of zonulin levels in blood stability of antibodies.血液中 zonulin 水平的波动与抗体的稳定性。
World J Gastroenterol. 2017 Aug 21;23(31):5669-5679. doi: 10.3748/wjg.v23.i31.5669.
3
Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression.人类肠道屏障通透性增加的血浆生物标志物——连蛋白和脂肪酸结合蛋白2，与焦虑或抑郁状态下的血浆内毒素及肠道微生物群改变相关。
Gut. 2018 Aug;67(8):1555-1557. doi: 10.1136/gutjnl-2017-314759. Epub 2017 Aug 16.
4
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.闭合蛋白，一种上皮和内皮屏障功能的调节因子，及其在慢性炎症性疾病中的作用。
Tissue Barriers. 2016 Oct 21;4(4):e1251384. doi: 10.1080/21688370.2016.1251384. eCollection 2016.
5
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.肥大细胞增多症：2016年世界卫生组织更新分类及新出现的治疗理念。
Blood. 2017 Mar 16;129(11):1420-1427. doi: 10.1182/blood-2016-09-731893. Epub 2016 Dec 28.
6
Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil.巴西东北部儿童环境肠病、炎症、发育迟缓及生长障碍的生物标志物
PLoS One. 2016 Sep 30;11(9):e0158772. doi: 10.1371/journal.pone.0158772. eCollection 2016.
7
Irritable bowel syndrome and the elusive mast cells.肠易激综合征与捉摸不定的肥大细胞。
Am J Gastroenterol. 2012 May;107(5):727-9. doi: 10.1038/ajg.2012.61.
8
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.肥大细胞增多症患者的抑郁：患病率、特征和马替尼治疗的效果。
PLoS One. 2011;6(10):e26375. doi: 10.1371/journal.pone.0026375. Epub 2011 Oct 21.
9
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.血清脂多糖结合蛋白和可溶性 CD14 是克罗恩病患者疾病活动的标志物。
Inflamm Bowel Dis. 2011 Mar;17(3):767-77. doi: 10.1002/ibd.21402. Epub 2010 Sep 23.
10
Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation.综述：可溶性固有免疫模式识别蛋白清除死亡细胞和细胞成分：对炎症加重或消退的影响。
Innate Immun. 2010 Jun;16(3):191-200. doi: 10.1177/1753425910369271.
Zotero 插件